Projecting the future impact of emerging SARS-CoV-2 variants under uncertainty: Modeling the initial Omicron outbreak
- PMID: 38452455
- PMCID: PMC11493339
- DOI: 10.1016/j.epidem.2024.100759
Projecting the future impact of emerging SARS-CoV-2 variants under uncertainty: Modeling the initial Omicron outbreak
Abstract
Over the past several years, the emergence of novel SARS-CoV-2 variants has led to multiple waves of increased COVID-19 incidence. When the Omicron variant emerged, there was considerable concern about its potential impact in the winter of 2021-2022 due to its increased fitness. However, there was also considerable uncertainty regarding its likely impact due to questions about its relative transmissibility, severity, and degree of immune escape. We sought to evaluate the ability of an agent-based model to forecast incidence in the context of this emerging pathogen variant. To project COVID-19 cases and deaths in Indiana, we calibrated our model to COVID-19 hospitalizations, deaths, and test-positivity rates through November 2021, and then projected COVID-19 incidence through April 2022 under four different scenarios that covered the plausible ranges of Omicron's severity, transmissibility, and degree of immune escape. Our initial projections from December 2021 through March 2022 indicated that under a pessimistic scenario with high disease severity, the peak in weekly COVID-19 deaths in Indiana would be larger than the previous peak in December 2020. However, retrospective analyses indicate that Omicron's severity was closer to the optimistic scenario, and even though cases and hospitalizations reached a new peak, fewer deaths occurred than during the previous peak. According to our results, Omicron's rapid spread was consistent with a combination of higher transmissibility and immune escape relative to earlier variants. Our updated projections starting in January 2022 accurately predicted that cases would peak in mid-January and decline rapidly over the next several months. The performance of our projections shows that following the emergence of a new pathogen variant, models can help quantify the potential range of outbreak magnitudes and trajectories. Agent-based models are particularly useful in these scenarios because they can efficiently track individual vaccination and infection histories with multiple variants with varying degrees of cross-protection.
Keywords: COVID-19; Forecasting; Omicron; SARS-CoV-2; Variant.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Authors declare that they have no competing interests.
Figures




Similar articles
-
SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis.JMIR Bioinform Biotechnol. 2023 Jan 10;4:e42700. doi: 10.2196/42700. eCollection 2023. JMIR Bioinform Biotechnol. 2023. PMID: 36688013 Free PMC article.
-
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35085225 Free PMC article.
-
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.Cell. 2021 Dec 22;184(26):6229-6242.e18. doi: 10.1016/j.cell.2021.11.026. Epub 2021 Nov 19. Cell. 2021. PMID: 34910927 Free PMC article.
-
Omicron SARS-CoV-2 variant of concern: A review on its transmissibility, immune evasion, reinfection, and severity.Medicine (Baltimore). 2022 May 13;101(19):e29165. doi: 10.1097/MD.0000000000029165. Medicine (Baltimore). 2022. PMID: 35583528 Free PMC article. Review.
-
Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.Rev Med Virol. 2022 Sep;32(5):e2381. doi: 10.1002/rmv.2381. Epub 2022 Jul 20. Rev Med Virol. 2022. PMID: 35856385 Free PMC article. Review.
References
-
- Borchering Rebecca K., Viboud C.écile, Howerton Emily, Smith Claire P., Truelove Shaun, Runge Michael C., Reich Nicholas G., et al., 2021. Modeling of future COVID-19 Cases, hospitalizations, and deaths, by vaccination rates and nonpharmaceutical intervention scenarios - United States, April-September 2021. Mmwr. Morb. Mortal. Wkly. Rep 70 (19), 719–724. - PMC - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous